Product image
InVivoPlus anti-mouse CD16/CD32
BP0307
Overview
- SupplierBio X Cell
- Product NameInVivoPlus anti-mouse CD16/CD32
- Delivery Days Customer7
- ApplicationsNeutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID2.4G2
- Concentration4-11 mg/ml
- HostRat
- IsotypeIgG2b
- ReactivityMouse
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling. Pasqual G et al., 2018 Jan 25, NatureRead more
- CD47 blockade triggers T cell-mediated destruction of immunogenic tumors. Liu X et al., 2015 Oct, Nat MedRead more
- IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis. Arbelaez CA et al., 2015 Sep 1, J ImmunolRead more
- Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. Peske JD et al., 2015 May 13, Nat CommunRead more
- A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects. Yu X et al., 2015 Jun, TransfusionRead more
- Loss of signalling via Galpha13 in germinal centre B-cell-derived lymphoma. Muppidi JR et al., 2014 Dec 11, NatureRead more
- The function of the chemokine receptor CXCR6 in the T cell response of mice against Listeria monocytogenes. Heesch K et al., 2014, PLoS OneRead more
- FoxP3+ regulatory T cells promote influenza-specific Tfh responses by controlling IL-2 availability. Leon B et al., 2014 Mar 17, Nat CommunRead more
- Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. Deng L et al., 2014 Feb, J Clin InvestRead more